Institutional allocators across Asia Pacific (Apac) are increasingly tailoring their private market strategies to capture structural growth in healthcare, balancing the high-risk potential of drug discovery against the stable demand generated by demographic ageing.
Rather than viewing demographic shifts purely as a liability, sophisticated investors are leaning into venture capital, private equity and thematic strategies to fund life sciences, digital healthcare and drug manufacturing.
In an exclusive interview with AsianInvestor, the sovereign investor's chief talked about how the fund is responding to heightened global risks and the challenges of AI.
Regional insurers continue to consider private credit, infrastructure debt and asset-backed finance even as their chief investment officers are increasingly focused on ensuring their balance sheets can withstand periods of market stress.
Singapore has strengthened its pitch to global asset managers, but the next test is turning policy announcements into clear rules and faster operating processes.
Major institutional investors across Asia are pouring capital into AI-linked infrastructure, expanding pension platforms and exploring new investment opportunities, while regulators revamp frameworks to support evolving capital flows.
As structural shifts replace globalisation with regionalisation, insurers are adapting strategic allocations through stricter risk management and shorter investment tenors.
AsianInvestor held its flagship Southeast Asia Institutional Investment Forum on November 22 in Singapore. The event was attended by a galaxy of heavyweight speakers and influential asset owners.
Drawn by moderate inflation, low market correlation and resilient structural demand, investors are shifting their Asia Pacific (Apac) real estate allocations into Japanese logistics.
As demand for private credit cools, regional investors are shifting capital into secondaries and real assets to gain stronger protections and clearer liquidity.
The Hong Kong single family office is deploying AI with founder Johnson Cheng predicting technology could eventually enable a one-person family office.
Facing volatility and complex global regulations, investors are adapting their strategies through international diversification, private credit investments and next-gen priorities like ESG.
Investors are increasingly adopting mid-market strategies, co-investments and secondary dislocations seeking geographical diversification and real cash returns.
Asian insurers are moving beyond tactical hedging, using derivatives to manage volatility, enhance capital efficiency, and strengthen portfolio construction.